Fabien Collangettes is a partner at Omnes Capital and has held multiple board member positions at various companies, including SeqOne Genomics, Capsule Corp. Labs, and Therapixel, among others. With experience as a board member at Themis Bioscience GmbH and Sentryo prior to their acquisitions, Fabien has a strong background in strategic oversight and investment. Educated with a Master of Science in Finance from Imperial College London, Fabien co-founded Tribway and served as Délégué Général at Paris Business Angels. Currently, Fabien is a board observer at Iktos and Qubit Pharmaceuticals, continuing to influence the tech and biotech sectors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices